Summit Securities Group’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Summit Securities Group’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,600	Closed	-$706K	–	1440
2021 Q4	$706K	Buy	+7,600	New	+$501K	0.03%	300

Summit Securities Group's ARNA Position: Q1 2022 in Review

Summit Securities Group sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 7,600 shares — an estimated $706K sold.

Summit Securities Group first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $706K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Summit Securities Group reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Summit Securities Group sold 7,600 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $706K.
Summit Securities Group first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Summit Securities Group's Arena Pharmaceuticals Inc position peaked at $706K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Summit Securities Group's 13F filing for Q1 2022, filed 11 May 2022.